Hepatitis C Treatment in Patients With Porphyria Cutanea Tarda.
CONCLUSIONS: HCV treatment regimens including interferon or ribavirin may precipitate PCT relapse. Hydroxychloroquine may be useful to prevent such relapses. In this limited experience, DAA were not associated with PCT relapse. Studies are needed to examine DAA as a primary PCT treatment in HCV-infected patients.
PMID: 28641714 [PubMed - in process]
Source: The American Journal of the Medical Sciences - Category: General Medicine Authors: Singal AK, Venkata KVR, Jampana S, Islam FU, Anderson KE Tags: Am J Med Sci Source Type: research
More News: General Medicine | Hepatitis | Hepatitis C | Hydroxychloroquine | Incivek | Porphyria | Study